Tirzepatide, the novel medication, is generating considerable interest within the scientific community. It functions differently from common diabetes medications, targeting multiple receptors involved in glucose regulation and appetite . Initial trials have demonstrated remarkable efficacy in lowering blood glucose in individuals with type 2 diabet